Lamivudine Stavudine & Nevirapine Tablets 150mg + 30mg + 200mg Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 150mg + 30mg + 200mg
Reference Brands: Generic formulations marketed under different names
Category: Anti Viral
Lamivudine Stavudine & Nevirapine Tablet is a medicine that is used for the treatment of Hiv Infection, Hepatitis B Virus Infection, Hiv-1 Infection and other conditions. Lamivudine Stavudine & Nevirapine Tablet contains Lamivudine, Nevirapine, and Satvudine as active ingredients. Lamivudine Stavudine & Nevirapine Tablet works by increasing the number of infection fighting cells in the body; blocking the activity of HIV-1 reverse transcriptase; stopping the reverse transcriptase from working, thus helps to control HIV-1 infection
Product Description:
Lamivudine Stavudine & Nevirapine Tablet is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms: · Hiv Infection · Hepatitis B Virus Infection · Hiv-1 Infection Lamivudine Stavudine & Nevirapine Tablet Working, Mechanism of Action and Pharmacology Lamivudine Stavudine & Nevirapine Tablet improves the patient's condition by performing the following functions: · Increasing the number of infection fighting cells in the body. · Blocking the activity of HIV-1 reverse transcriptase. · Stopping the reverse transcriptase from working, thus helps to control HIV-1 infection.
Lamivudine Stavudine & Nevirapine Tablets — third party manufacturing & bulk supply
Lamivudine Stavudine & Nevirapine Tablets 150mg + 30mg + 200mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Indicative minimum order quantity
Lamivudine Stavudine & Nevirapine Tablets is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Lamivudine Stavudine & Nevirapine Tablets listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Lamivudine Stavudine & Nevirapine Tablet... →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Lamivudine, Stavudine, and Nevirapine are used together as a fixed-dose combination for the treatment of HIV-1 infection. This combination helps lower the viral load, improve immune function, and slow disease progression as part of antiretroviral therapy.
It is made from the active pharmaceutical ingredients lamivudine, stavudine, and nevirapine. These three antiretroviral agents belong to nucleoside reverse transcriptase inhibitors (lamivudine and stavudine) and a non-nucleoside reverse transcriptase inhibitor (nevirapine).
Common trade names include Triomune and several other regional fixed-dose combination brands.
Triomune was originally manufactured by Cipla, and various other approved pharmaceutical companies in India and other countries also manufacture this combination in generic form.
The generic name is lamivudine + stavudine + nevirapine fixed-dose combination.
Brand names include Triomune and multiple other generic brands depending on the manufacturer.
This combination is commonly manufactured in India by several WHO-approved and GMP-certified pharmaceutical companies, and also in other regions depending on regulatory approvals.
Related Products
Brincidofovir
Strength:
100 mg, 10 mg/ml
Form: Tablets / Oral suspension
Reference Brands: Tembexa (USA/EU)
View DetailsLenacapavir
Strength:
300 mg, 463.5 mg/1.5 mL
Form: Tablet / Injection
Reference Brands: Yeztugo (USA), Sunlenca (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers